Chemotherapy in Treating Patients Who Have Hematologic Cancer
NCT00004047
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
INDUSTRY
Sponsor class
Conditions
Leukemia
Myelodysplastic Syndromes
Interventions
DRUG:
exatecan mesylate
Sponsor
Daiichi Sankyo